Summary
Updated Aug 30, 2026
James M. Detore is Chief Financial Officer of CG Oncology, Inc. (CGON). 1 SEC Form 4 filing on record, dated 16 April 2026.
Trading Pattern
InsiderAlpha's records for James M. Detore go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies James M. Detore files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Brian Guan-Chyun Liu - $74.81M of CGON open-market activity in the last 12 months
- James Mulay - $6.28M of CGON open-market activity in the last 12 months
- Hong Fang Song - $2.78M of CGON open-market activity in the last 12 months
- Leonard E. Post - $1.22M of CGON open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is James M. Detore?
James M. Detore is a corporate insider, tracked as Chief Financial Officer of CG Oncology, Inc. (CGON). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did James M. Detore last file a Form 4?
The only primary Form 4 on record is dated 16 April 2026.
Where can I see all of James M. Detore's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow James M. Detore and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial